Class information for:
Level 1: ANTI TNF ALPHA THERAPIES//GENHOTEL RECH EUROPEEN POLYARTHRITE RHUMATOID//PATHOL RHEUMATOL

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
23191 300 40.4 91%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
389 16325 RHEUMATOID ARTHRITIS//RHEUMATOLOGY//RHEUMATOL

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
1 ANTI TNF ALPHA THERAPIES Author keyword 2 67% 1% 2
2 GENHOTEL RECH EUROPEEN POLYARTHRITE RHUMATOID Address 2 67% 1% 2
3 PATHOL RHEUMATOL Address 2 67% 1% 2
4 TNFR II Author keyword 2 67% 1% 2
5 UNITE MIXTE HOSPICES CIVILS LYON BIOMERIEUX Address 2 67% 1% 2
6 ECRAF Address 2 50% 1% 3
7 MOL IMMUNOGENET GRP Address 2 18% 3% 8
8 GRP RECERCA REUMATOL Address 1 40% 1% 2
9 IIS LA PRINCESA Address 1 40% 1% 2
10 TNF ALPHA 308 POLYMORPHISM Author keyword 1 40% 1% 2

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
LCSH search Wikipedia search
1 ANTI TNF ALPHA THERAPIES 2 67% 1% 2 Search ANTI+TNF+ALPHA+THERAPIES Search ANTI+TNF+ALPHA+THERAPIES
2 TNFR II 2 67% 1% 2 Search TNFR+II Search TNFR+II
3 TNF ALPHA 308 POLYMORPHISM 1 40% 1% 2 Search TNF+ALPHA+308+POLYMORPHISM Search TNF+ALPHA+308+POLYMORPHISM
4 ANTI TNF ALPHA BLOCKERS 1 50% 0% 1 Search ANTI+TNF+ALPHA+BLOCKERS Search ANTI+TNF+ALPHA+BLOCKERS
5 ANTI TNF RESPONSE 1 50% 0% 1 Search ANTI+TNF+RESPONSE Search ANTI+TNF+RESPONSE
6 GENE PROFILE EXPRESSION 1 50% 0% 1 Search GENE+PROFILE+EXPRESSION Search GENE+PROFILE+EXPRESSION
7 IL 6 POLYMORPHISMS 1 50% 0% 1 Search IL+6+POLYMORPHISMS Search IL+6+POLYMORPHISMS
8 INDIVIDUALIZED THERAPEUTICS 1 50% 0% 1 Search INDIVIDUALIZED+THERAPEUTICS Search INDIVIDUALIZED+THERAPEUTICS
9 JUSTICIA GENDARUSSA BURMF 1 50% 0% 1 Search JUSTICIA+GENDARUSSA+BURMF Search JUSTICIA+GENDARUSSA+BURMF
10 SHARP VAN DER HEIJDE 1 50% 0% 1 Search SHARP+VAN+DER+HEIJDE Search SHARP+VAN+DER+HEIJDE

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
1 TNF ALPHA 308 G A POLYMORPHISM 14 100% 2% 7
2 POSITION 308 5 54% 2% 7
3 P55 GENE 4 56% 2% 5
4 ALPHA BLOCKING AGENTS 4 35% 3% 9
5 676T GREATER THAN G POLYMORPHISM 3 100% 1% 3
6 ANTI TNF TREATMENT 3 31% 3% 8
7 FACTOR RECEPTOR II 2 23% 2% 7
8 INTERFERON SIGNATURE 1 31% 1% 4
9 HUMAN AUTOIMMUNE DISEASE 1 38% 1% 3
10 M196R POLYMORPHISM 1 100% 1% 2

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Tumour necrosis factor alpha-308G -> A polymorphism is not associated with response to TNF alpha blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis 2010 39 32 66%
Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response 2011 46 79 41%
Gene expression analysis in RA: towards personalized medicine 2014 10 153 24%
Current and future trends in biomarker discovery and development of companion diagnostics for arthritis 2015 2 121 21%
The potential use of expression profiling: implications for predicting treatment response in rheumatoid arthritis 2013 8 43 35%
Biomarkers for prediction of TNF alpha blockers response in rheumatoid arthritis 2010 14 55 58%
Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritis 2015 1 102 30%
Pharmacogenomics of biological treatment in rheumatoid arthritis 2014 2 49 49%
Does polymorphysm of genes coding for pro-inflammatory mediators predict the clinical response to tnf alpha blocking agents? A review analysis of the literature 2011 12 38 53%
Genetic and genomic predictors of anti-TNF response 2011 18 81 40%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
1 GENHOTEL RECH EUROPEEN POLYARTHRITE RHUMATOID 2 67% 0.7% 2
2 PATHOL RHEUMATOL 2 67% 0.7% 2
3 UNITE MIXTE HOSPICES CIVILS LYON BIOMERIEUX 2 67% 0.7% 2
4 ECRAF 2 50% 1.0% 3
5 MOL IMMUNOGENET GRP 2 18% 2.7% 8
6 GRP RECERCA REUMATOL 1 40% 0.7% 2
7 IIS LA PRINCESA 1 40% 0.7% 2
8 SECT MUSCULOSKELETAL SCI 1 17% 1.3% 4
9 FEDERATIF RECH MULTIDISCIPLINAIRE PEPTIDES 2 1 21% 1.0% 3
10 BIOMED MED PHARM 1 50% 0.3% 1

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000194971 ABATACEPT//TOCILIZUMAB//DISEASE MODIFYING ANTIRHEUMATIC DRUGS
2 0.0000191484 TNF ALPHA GENE POLYMORPHISM//MOL LIFESCI//VA NEGOVSKY GEN REANIMATOL
3 0.0000183554 HANS WILSDORF//CLIN IMMUNOL UNITHANS WILSDORF//IMMUNOL ALLERGYCLIN IMMUNOL UNIT
4 0.0000181145 CIBER BBN SALUD CARLOS 3//RIER RED INFLAMAC ENFERMEDADES REUMAT//PROTEORED ISCIII PROTE GRP
5 0.0000171083 PTPN22//PROTEIN TYROSINE PHOSPHATASE NONRECEPTOR 22//IRF5
6 0.0000152227 FIBROBLAST LIKE SYNOVIOCYTES//BEREICH MOL MED MUSKULOSKELETALEN SYST//ABORATING MOL BIOL NOVEL THER EUT STRA
7 0.0000134913 MERIEUX//BLOOD TRANSCRIPTOME//DUTCH NUTRIGENOM CONSORTIUM
8 0.0000108189 SHARED EPITOPE//HLA DRB1//HLA DR4
9 0.0000104098 UNC93B1//MARY KIRKLAND LUPUS//TLR7
10 0.0000096291 PALINDROMIC RHEUMATISM//RECURRENT ARTHRITIS//INTERMITTENT HYDRARTHROSIS